There’s ‘nothing thesis-changing’ about Coinbase despite fourth-quarter beat, some Wall Street firms say
The cryptocurrency exchange topped earnings and revenue estimates in its fourth-quarter earnings, but it also posted user numbers that disappointed analysts.
UBS downgrades Logitech, cites rising competition for the computer peripherals maker
The Swiss-American company will have to navigate several challenging quarters amid rising inflation and a weaker consumer, read a UBS note.
Jennifer McClellan makes history as the first Black woman elected to Congress in Virginia
The Democratic state senator won a special election Tuesday in Virginia’s 4th Congressional District.
Citi upgrades Alcoa, says aluminum producer is a buy with China reopening
The bank upgraded shares to buy from neutral, saying Alcoa is about to get a boost from the world’s second largest economy.
This little-known health stock that uses A.I. can rally more than 120%, Canaccord Genuity says
The firm believes artificial intelligence will increasingly be used in diagnostics and life science tools going forward.
Bentley to end production of ultra-performance 12-cylinder engine as it transitions to EVs
Bentley Motors plans to end production of its 12-cylinder engine next April as the famed luxury carmaker transitions to electric vehicles.
Supreme Court justices in Google case express hesitation about upending Section 230
Justices across the ideological spectrum expressed concern with breaking the delicate balance set by Section 230 in their ruling.
Georgia grand jury recommended charging multiple people in Trump election probe for range of crimes, report says
A Georgia grand jury spent months gathering evidence into former President Donald Trump’s effort to reverse his 2020 loss to President Joe Biden.
Amazon employees push CEO Andy Jassy to drop return-to-office mandate
Amazon tech workers created an internal petition and Slack channel to share their grievances about the return-to-work mandate.
Pfizer RSV vaccine that protects infants could receive FDA approval this summer
The single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
